FN1 and breast carcinoma: Interfering with Fibronectin (and collagen) accumulation using pUR4 led to smaller tumors as evaluated by bioluminescence imaging (BLI) and osteolytic area on x-rays in the breast cancer model and as evaluated by weight and volume in the melanoma model.